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Abstract 
The gingival fluid of pregnant women was studied for interleukins 8 and 10, and immunoglobulins A and G in 31 
female patients of SHI CH No.5 of Volgograd, at the age of 20-25 years - the first period of adulthood 
(Iordanishvili A.K., 2015), 15 of which - without IDA, and 16 - with manifestations of IDA. Treatment of mild 
and moderate periodontitis (K05.3) was carried out in pregnant women with IDA with the use of Lysobact; 
pregnant women without IDA were treated with traditional anti-inflammatory therapy according to the 
treatment algorithm. In both groups, professional oral hygiene, active training and monitoring of the 
performance of individual hygiene were carried out. 
It was established that the concentration of IL-10 increases significantly (p <0.05) from 0.010 [1.790] ng/ml to 
3.050 [8.550] ng/ml after treatment, against the background of complex treatment of periodontitis in pregnant 
women with IDA with Lysobact. This confirms the importance of interleukin 10 as the main anti-inflammatory 
cytokine and objectively proves the correctness of the selected clinical tactics for treating mild and moderate 
inflammatory periodontal diseases with the drug "Lysobact" against the background of iron deficiency anemia. 
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INTRODUCTION: 
Morbidity among pregnant women is an actual 
problem of the present, as it negatively affects not 
only the health of the mother, but also her child’s 
health. As before, the leading pathology remains 
anemia, registered in 95.0% of pregnant women, 
and up to 40.0% of non-pregnant women of 
reproductive age [4,6]. Pregnant women are a group 
of high-risk of dental diseases, provoked by 
anemia. During pregnancy, the prevalence of mild 
to moderate gingivitis and periodontitis varies from 
49.1% to 100% (Kirilova E.N., 2009; Gaffield 
M.L., Colley B.J., 2009). 
 
Drugs used in periodontology are often 
contraindicated to pregnant women, since they can 
have embryotoxic, embryo-lethal, teratogenic, and 
fetotoxic effects [1,7]. 
 
At the same time, the literature lacks information 
on the oral condition of pregnant women with iron 
deficiency anemia in the course of complex 
treatment of periodontal diseases, in conjunction 
with the indices of local immunity of the oral cavity 
and general obstetrical status. 
 
Objective of the research is to study clinical and 
immunological features of inflammatory 
periodontal diseases in women with a physiological 
and pathological course of pregnancy against the 
background of iron deficiency anemia. 
 
MATERIALS AND METHODS: 
The laboratory study of the gingival fluid was 
performed in 31 pregnant women in the State 
Penitentiary Hospital No. 5 in Volgograd, at the age 
of 22-35 years - the first period of adulthood (age 
periodization of the Institute of Age Physiology of 
the RAMS) (Iordanishvili A.K., 2015), 15 of which 
are pregnant women without IDA, and 16 have 
formed the group with manifestations of iron 
deficiency anemia.  
 
In both groups, professional oral hygiene, active 
training and monitoring of the performance of 
individual hygiene were carried out. 
 
Treatment of mild to moderate periodontitis 
(K05.3) in pregnant women with IDA was 
conducted with the use of Lysobact. Lysobact, due 
to its antiseptic and antiviral effect, is a drug of 
choice for pregnant women, who have trouble 
finding adequate, sparing and at the same time 
effective treatment. The drug enhances nonspecific 
immunity and maintains a normal balance of 
microflora in the oral cavity. The drug was used in 
the form of orodispersible tablets.  
 
Pregnant women without IDA received traditional, 
in accordance with the treatment algorithm, anti-
inflammatory therapy (Dmitrieva L.A., 2009).  
 
The gingival fluid of pregnant women was studied 
for interleukins 8 and 10, immunoglobulins A and 
G (Table 1). 
 
The concentration of immunoglobulins A and G in 
the gingival fluid was determined by olid-phase 
enzyme immunoassay using IgGtot-IFA-BEST and 
IgA secretory-IFA-BEST diagnostic kits (CJSC 
vector BEST, Russia).Cytokine content in the 
gingival fluid was determined by solid-phase 
enzyme-linked immunosorbent assay, and the 
concentration of interleukins 8 and 10 in the 
gingival fluid was determined using 
INTERLEYKIN-8-IFA-BEST and IgA secretory-
IFA-BEST diagnostic kits (CJSC vector BEST, 
Russia).In the course of the studies we used: Elmi 
SkyLine Shaker ST-3 thermostatable shaker (Elmi, 
Latvia) at 700 rpm in the range of 37±1°C, StatFax 
2600 microplate reader (Stat Fax, USA), Stat Fax 
2100 plate immunoassay analyzer (Stat Fax, USA),  
 
 
Table 1: The minimum volume of laboratory tests. 
 
 IgA IgG IL-8 IL-10 
IDA patients after treatment 16 16 16 16 
IDA patients before 
treatment 
16 16 16 16 
Non-IDA patients after 
treatment 
15 15 15 15 
Non-IDA patients before 
treatment 
15 15 15 15 
Total 62 62 62 62 
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and laboratory utensils and consumables. 
Immunoenzymatic analysis was performed in 
accordance with the instructions for the devices and 
reagents.Total 248 immunological studies were 
performed.  
The results were recorded using a flatbed analyzer, 
measuring the optical density in a single-wave 
mode: the main filter was 450 nm. The 
concentration of immunoglobulins and cytokines 
was calculated using the calibration plot with the 
Concentration/Optical density coordinates. 
Statistical processing of the results was performed 
using Microsoft Office 2007 and Statistica 6.0 
software packages. The data were checked for 
normality using the asymmetry-excess criterion. 
The test revealed a difference in the distribution 
from normal, so a nonparametric Mann-Whitney 
test was used to compare the results in patient 
groups. The median and interquartile range were 
used as descriptive statistics. 
 
RESULTS: 
DETERMINATION OF THE 
CONCENTRATION OF 
IMMUNOGLOBULINS IN THE GINGIVAL 
FLUID. 
1. Determination of the concentration of 
immunoglobulins in the gingival fluid of 
pregnant women without IDA. 
The concentration of secretory immunoglobulin A 
in the gingival fluid of pregnant women without 
iron deficiency anemia before treatment was 148.0 
[112.0] mg/l, in the course of treatment - 112.0 
[117.0] mg/l (Table 2). There were no statistically 
significant differences between these groups 
according to the Mann-Whitney test. It is shown 
that pregnant women have an increased level of 
immunoglobulin A secretion with salivary glands in 
comparison with non-pregnant ones [5]. Perhaps, 
the treatment does not significantly affect the 
background secretion of IgA.  
 
The level of IgG in the gingival fluid examined 
before the treatment was 7.1 [8.5] mg/ml, after 
treatment - 5.7 [8.7] mg/ml. There were no 
significant differences according to the Mann-
Whitney test between these indicators. It is known 
that the level of IgG in the gingival fluid is 
determined by the serum level of this 
immunoglobulin and the activity of 
immunocompetent cells in the salivary glands [8]. 
 An increase in the level of immunoglobulins in the 
gingival fluid is usually associated with 
inflammatory processes. The absence of significant 
differences in the level of immunoglobulins can be 
explained by the absence of active inflammation in 
the examined patients without IDA [5].  
2. Determination of the concentration of 
immunoglobulins in the gingival fluid of 
pregnant women with IDA. 
The level of secretory IgA in the gingival fluid of 
pregnant women with iron deficiency anemia 
before treatment with Lysobact was 312.0 [311.0] 
mg/l, after treatment - 187.0 [264.0], respectively 
(Table 3).  
 
 
Table 2:Immunoglobulin levels in the gingival fluid of pregnant women without IDA: median 
[interquartile range]. 
Indicator 
Non-IDA pregnant women before 
treatment 
Non-IDA pregnant women after 
treatment 
sIgA, mg/l 148.0 [112.0] 112.0 [117.0] 
IgG, mg/ml 7.1 [8.5] 5.7 [8.7] 
 
 
Table 3. Immunoglobulin levels in the gingival fluid of pregnant women with IDA: median [interquartile 
range]. 
Indicator 
IDA pregnant women before 
treatment 
IDA pregnant women after 
treatment 
sIgA, mg/l 312.0 [311.0] 187.0 [264.0] 
IgG, mg/ml 7.3 [8.9] 4.1 [4.7] 
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The concentration of IgG in the gingival fluid of 
pregnant women against the background of iron 
deficiency anemia was 7.3 [8.9] mg/ml before 
treatment and 4.1 mg/ml after treatment, 
respectively [4,5]. There were no statistically 
significant differences in the levels of 
immunoglobulins of the gingival fluid. Perhaps, this 
is due to a slight change in the synthetic activity of 
plasma cells of salivary glands before and after 
therapy with Lysobact.  
Comparison of immunoglobulin levels in the 
gingival fluid showed no statistically significant 
differences between the anemia group after 
treatment and the rest of the examined groups 
(Table 4). Perhaps, the therapy with Lysobact 
reduces inflammatory manifestations in the oral 
cavity, and thus the production of immunoglobulins 
by plasmatic cells of the salivary glands does not 
exceed the level of healthy patients without 
pathology (without IDA). 
 
Statistically significant differences in the secretory 
IgA content in the gingival fluid of patients with 
IDA before treatment with Lysobact from that in 
patients without anemia before and after treatment 
were revealed. The level of immunoglobulin A 
secretion on the background of iron deficiency 
anemia before treatment was increased in 
comparison with both groups without IDA. The 
literature data suggest the opposite: iron deficiency 
reduces the activity of the blast-transformation of 
lymphocytes, as well as the production of secretory 
IgA [5].  
 
Table 4: Immunoglobulin levels in the gingival fluid of pregnant women without IDA and against anemia: 
median [interquartile range]. 
Indicator 
Non-IDA pregnant 
women before 
treatment 
Non-IDA pregnant 
women after 
treatment 
IDA pregnant women 
before treatment 
IDA pregnant 
women after 
treatment 
sIgA, mg/l 148.0 [112.0] 112.0 [117.0] 312.0 [311.0]*# 187.0 [264.0] 
IgG, mg/ml 7.1 [8.5] 5.7 [8.7] 7.3 [8.9] 4.1 [4.7] 
Note: 
* - differences according to the Mann-Whitney test from the group without IDA before treatment, p<0.05 
# - differences according to the Mann-Whitney test from the group without IDA after treatment, p<0.05 
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Fig.1. Levels of secretory immunoglobulin A in the examined patients, mg/l. 
Note: 
* - differences according to the Mann-Whitney test from the group without IDA before treatment, p<0.05. 
# - differences according to the Mann-Whitney test from the group without IDA after treatment, p<0.05. 
 
DETERMINATION OF THE 
CONCENTRATION OF INTERLEUKINS IN 
THE GINGIVAL FLUID. 
1. Determination of the concentration of 
interleukins in the gingival fluid of pregnant 
women without IDA. 
The concentration of interleukin-8 in the gingival 
fluid of female patients without IDA before 
treatment was 70.80 [144.35] ng/ml, after treatment 
- 123.30 [191.80] ng/ml (Table 5).  
 
Table 5. Interleukin levels in the gingival fluid of pregnant women without IDA: median [interquartile 
range]. 
Indicator 
Non-IDA pregnant women before 
treatment 
Non-IDA pregnant women after 
treatment 
IL-8, ng/ml 70.80 [144.35] 123.30 [191.80] 
IL-10, ng/ml 0.001 [1.259] 2.900 [18.640]* 
Note: * - differences according to the Mann-Whitney test from the group without IDA before treatment, p<0.05 
 
*# 
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No statistically significant differences were found 
between these groups. The obtained result does not 
disagree with the data of other authors cited in the 
literature [3]. 
 
The level of interleukin-10 in the gingival fluid of 
the examined women without IDA before treatment 
was 0.001 [1.259] ng/ml, and after treatment - 
2.900 [18.640] ng/ml, which is significantly higher. 
IL-10 is the main anti-inflammatory cytokine, 
which explains the increase in its production 
against the background of treatment of 
periodontitis. 
2. Determination of the concentration of 
interleukins in the gingival fluid of pregnant 
women with IDA. 
Analysis of the content of interleukins in the 
gingival fluid of pregnant women on the 
background of IDA showed statistically 
insignificant changes in IL-8 content: 253.25 
[307.23] ng/ml before treatment and 110.0 [137.0] 
ng/ml after treatment (Table 6). The studies of other 
authors also point to minor changes established in 
this indicator [8]. 
 
The concentration of IL-10 on the background of 
treatment with Lysobact significantly increases 
(3.050 [8.550] ng/ml) as compared with the level 
before treatment (0.010 [1.790] ng/ml). Data from 
the literature also confirm the results; the reduction 
in the inflammatory process in the dentogingival 
pockets is associated with increased production of 
interleukin IL-10 [2]. 
 
During the processing of the obtained data, 
statistically significant differences in the level of 
interleukin-10 in the group with IDA after 
treatment were revealed, as comparison with the 
group without IDA before treatment (Table 7).  
 
Table 6: Interleukin levels in the gingival fluid of pregnant women with IDA: median [interquartile 
range]. 
 
Indicator IDA pregnant women before treatment IDA pregnant women after treatment 
IL-8, ng/ml 253.25 [307.23] 110.0 [137.0] 
IL-10, ng/ml 0.010 [1.790] 3.050 [8.550]* 
Note: * - differences according to the Mann-Whitney test from the group with IDA before treatment, p<0.05 
 
 
Table 7:  Interleukin levels in the gingival fluid of pregnant women without IDA and against anemia: 
median [interquartile range]. 
 
Indicator 
Non-IDA pregnant 
women before 
treatment 
Non-IDA pregnant 
women after 
treatment 
IDA pregnant women 
before treatment 
IDA pregnant 
women after 
treatment 
IL-8, ng/ml 70.80 [144.35] 123.30 [191.80] 253.25 [307.23] 110.0 [137.0] 
IL-10, ng/ml 0.001 [1.259] 2.900 [18.640] 0.010 [1.790] 3.050 [8.550]* 
Note: * - differences according to the Mann-Whitney test from the group without IDA before treatment, p<0.05. 
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Fig. 1. Levels of IL-10 in the gingival fluid of female patients, ng/ml. 
Note: 
* - differences according to the Mann-Whitney test from the group without IDA before treatment, p<0.05 
# - differences according to the Mann-Whitney test from the group with IDA before treatment, p<0.05 
 
The obtained results on the level of interleukins in 
the gingival fluid of pregnant women are consistent 
with the earlier literature data [2]. 
 
CONCLUSION: 
The study of clinical and immunological 
peculiarities of inflammatory periodontal diseases 
in women with a physiological and pathological 
course of pregnancy against the background of iron 
deficiency anemia made it possible to establish the 
following. 
 
Immunological indicator IL-10 is the main anti-
inflammatory cytokine, which explains the increase 
in its production against the background of complex 
treatment of mild to moderate periodontitis (K05.3), 
confirming literature data that the decrease in the 
inflammatory process in the dentogingival pockets 
is associated with increased production of 
interleukin IL-10 [2,3]. 
 
SUMMARY: 
Thus, in the course of a combination treatment of 
inflammatory periodontal diseases in pregnant 
women with IDA, the concentration of IL-10 
increases significantly (p <0.05) from 0.010 [1.790] 
ng/ml to 3.050 [8.550] ng/ml after treatment with 
Lysobact. This objectively proves the correctness of 
the selected clinical tactics for treating mild and 
moderate inflammatory periodontal diseases with 
Lysobact against the background of iron deficiency 
anemia. 
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